Advertisement

Picture Demy-Colton BioFuture 2021 NYC C Virtual Option 650x80px
Document › Details

InflaRx GmbH. (3/29/18). "Press Release: InflaRx Full Year 2017 Financial & Operating Results". Jena.

Organisations Organisation InflaRx N.V. (Nasdaq Global Select Market: IFRX)
  Group InflaRx (Group)
  Organisation 2 Nasdaq
  Group Nasdaq OMX (Group)
Products Product IFX-1 (InflaRx)
  Product 2 investment banking
  Index term 2 InflaRx–SEVERAL: investment, 201711 IPO $100m w 6.667m common shares at $15/share at Nasdaq Global Select Market
Persons Person Riedemann, Niels C. (InflaRx 200803 Managing Director + founder)
  Person 2 Gibney, Tony (FogPharma 202005– CBO + CFO before Achillion Pharma + Leerink Partners + Merrill Lynch + Lehman Brothers)
     


   
Record changed: 2018-04-08

Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for InflaRx (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture [iito] Back into Ad 650x80px




» top